S9, a Novel Anticancer Agent, Exerts Its Anti-Proliferative Activity by Interfering with Both PI3K-Akt-mTOR Signaling and Microtubule Cytoskeleton
Chao Zhang(Anhui Agricultural University), Jian Ding(Center for Translational Molecular Medicine)
Cited by 55
Related Papers
<i>Grateloupia longifolia</i> polysaccharide inhibits angiogenesis by downregulating tissue factor expression in HMEC‐1 endothelial cells
|British Journal of Pharmacology|2006|50
c-Jun Protects Hypoxia-Inducible Factor-1α from Degradation via Its Oxygen-Dependent Degradation Domain in a Nontranscriptional Manner
|Cancer Research|2009|49
α2,6-hyposialylation of c-Met abolishes cell motility of ST6Gal-I-knockdown HCT116 cells
|Acta Pharmacologica Sinica|2009|29
C11, a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor, suppresses breast cancer metastasis and angiogenesis
|Acta Pharmacologica Sinica|2018|29
MT119, a new planar‐structured compound, targets the colchicine site of tubulin arresting mitosis and inhibiting tumor cell proliferation
|International Journal of Cancer|2010|25